The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
Open accessAbstract
A randomised double-blind, placebo-controlled trial of high-dose, pulsed intravenous methylprednisolone was carried out in 50 individuals with multiple sclerosis; 22 patients were in acute relapse and 28 had chronic progressive disease. After a baseline assessment using the Kurtzke functional and expanded disability status scales each patient was randomly allocated to intravenous treatment with methylprednisolone (500 mg) or a saline placebo administered as a single daily dose for 5 days. Clinical assessments were repeated at 1 and 4 weeks after starting treatment. The results from all 50 patients showed a highly significant effect in favour of methylprednisolone treatment (p less than 0.001). In patients with relapse, there was a significant decrease in clinical disability scores at 1 and 4 weeks in the methylprednisolone treated group compared with controls (p less than 0.05 for each comparison). In the chronic progressive group, disability scores at 4 weeks only were significantly lower after treatment with methylprednisolone (p less than 0.01), mainly attributable to improvement in pyramidal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765
CONFAVREUX, C., AIMARD, G., & DEVIC, M. (1980) · Brain · doi:10.1093/brain/103.2.281 · Cited by 494
DIAGNOSIS AND CLASSIFICATION OF MULTIPLE SCLEROSIS
MCDONALD, W. I., & HALLIDAY, A. M. (1977) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071393 · Cited by 446
Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy
Ponticelli, C. E., Zucchelli, P. C., Imbasciati, E., Cagnoli, L., Pozzi, C., Passerini, P., Grassi, C., Limido, D., Pasquali, S., Volpini, T., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404123101503 · Cited by 380
Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo—final report
(1970) · Neurology · doi:10.1212/wnl.20.5_part_2.1 · Cited by 259
BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS
Cathcart, E., Scheinberg, M., Idelson, B., & Couser, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91272-1 · Cited by 246
MULTIPLE SCLEROSIS TREATMENT OF ACUTE EXACERBATIONS WITH CORTICOTROPHIN (A.C.T.H.)
Miller, H., NEWELL, D. J., & Ridley, A. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91030-3 · Cited by 123
Intravenous methylprednisolone for multiple sclerosis in relapse.
Barnes, M. P., Bateman, D. E., Cleland, P. G., et al. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.2.157 · Cited by 118
Imbasciati, E., Gusmano, R., Edefonti, A., et al. (1985) · BMJ · doi:10.1136/bmj.291.6505.1305 · Cited by 81
Methylprednisolone therapy in multiple sclerosis.
Newman, P. K., Saunders, M., & Tilley, P. J. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.10.941 · Cited by 22
Cited by
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
(1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488
Metadata
- Authors
- Milligan, N. M., Newcombe, R., & Compston, D. A.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1987-05-01
- Volume
- 50
- Issue
- 5
- Pages
- 511-516
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2037151912
- Cited by
- 364
- References
- 11
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. https://app.cochat.ai/papers/10.1136/jnnp.50.5.511
- The paper
- Milligan, N. M., Newcombe, R., & Compston, D. A. (1987). A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.5.511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.